RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Odonate Therapeutics Market capitalization 2024

Odonate Therapeutics Market capitalization

18.73 B USD

Odonate Therapeutics Dividend yield

Ticker

ODTC

ISIN

US6760791060

WKN

A2H9FC

In 2024, Odonate Therapeutics's market cap stood at 18.73 B USD, a -80.63% increase from the 96.69 B USD market cap in the previous year.

The Odonate Therapeutics Market capitalization history

YEARREVENUE (undefined USD)GROSS MARGIN (%)NET INCOME (undefined USD)
2020---
2019---
2018---
2017---
2016---
2015---

Odonate Therapeutics Aktienanalyse

What does Odonate Therapeutics do?

Odonate Therapeutics Inc is a biopharmaceutical company that specializes in the development of medications to assist patients with serious illnesses. The company was founded in 2013 by a team of experienced scientists, doctors, and experts from the pharmaceutical industry, with the goal of creating a revolutionary alternative to conventional cancer therapy. The idea was to develop a therapy that minimizes the unwanted effects of chemotherapy and radiation, while still being equally effective in fighting cancer. The business model of Odonate Therapeutics is based on the development of medications that specifically target certain substances in order to achieve maximum effectiveness and efficiency. The company primarily focuses on the research and development of cancer therapeutics and has already brought several innovative products to market, which are currently in the clinical testing phase. One of the main areas of Odonate Therapeutics' research and development is medication based on taxanes. Taxanes are a class of medications known for their effectiveness in fighting cancer. Odonate Therapeutics has the innovative idea of combining these substances with others to minimize the side effects of taxanes. The goal is to create a new generation of medications that offer a targeted approach to fighting cancer. Another focus of Odonate Therapeutics is the development of medications for the treatment of patients with breast cancer. The company has already conducted several testing phases for its flagship product, Odonate Therapeutics' Tesetaxel. Tesetaxel is a novel chemotherapy drug that aims to achieve higher efficacy with lower side effects. The results of the studies have been promising and have the potential to change the lives of patients with breast cancer. Another product developed by Odonate Therapeutics is the medication Odonate Therapeutics' Ladiratuzumab Vedotin. This is a cancer drug that was developed in phase 1 studies and is suitable for the treatment of patients with solid tumors. In this study, it has been shown to be well-tolerated and has shown promising results in fighting cancer cells. Over the past few years, Odonate Therapeutics Inc has achieved an impressive track record by developing innovative medications that have the potential to improve patients' lives. The research and development of cancer therapeutics is an area that requires increasing attention, as cancer remains one of the leading causes of death worldwide. Odonate Therapeutics aims to address this challenge by developing innovative products that meet the needs of patients. Overall, Odonate Therapeutics has quickly established a strong reputation in the biotech industry, and the company appears to be on a good path. The company has many promising medication pipeline programs, and the management team consists of experienced leaders focused on developing therapeutics and improving patients' quality of life. Odonate Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring Odonate Therapeutics's Market Capitalization

Odonate Therapeutics's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Odonate Therapeutics's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Odonate Therapeutics's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Odonate Therapeutics’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Odonate Therapeutics Stock

What is the current Odonate Therapeutics market capitalization?

The current market capitalization of Odonate Therapeutics is 18.73 B USD.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Odonate Therapeutics.

How has the market capitalization of Odonate Therapeutics developed in recent years?

The market capitalization of Odonate Therapeutics has increased/decreased by -80.63% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of Odonate Therapeutics?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of Odonate Therapeutics?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of Odonate Therapeutics have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does Odonate Therapeutics pay?

Over the past 12 months, Odonate Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Odonate Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Odonate Therapeutics?

The current dividend yield of Odonate Therapeutics is .

When does Odonate Therapeutics pay dividends?

Odonate Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Odonate Therapeutics?

Odonate Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Odonate Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Odonate Therapeutics located?

Odonate Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Odonate Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Odonate Therapeutics from 6/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/3/2024.

When did Odonate Therapeutics pay the last dividend?

The last dividend was paid out on 6/3/2024.

What was the dividend of Odonate Therapeutics in the year 2023?

In the year 2023, Odonate Therapeutics distributed 0 USD as dividends.

In which currency does Odonate Therapeutics pay out the dividend?

The dividends of Odonate Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Odonate Therapeutics

Our stock analysis for Odonate Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Odonate Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.